Scilex Holding Company announced the commercial launch of ELYXYB in the U.S. Starting today, ELYXYB is available in pharmacies to customers and supplied through their normal wholesaler and distributor channels.
Scilex Holding Company announced the commercial launch of ELYXYB in the U.S. Starting today, ELYXYB is available in pharmacies to customers and supplied through their normal wholesaler and distributor channels.
New option listings for February 24th include 11 Good Energy Inc (ELVN), Elbit Systems (ESLT), STG Group Inc (GDEF), and UFP Technologies (UFPT). Option delistings effective February 24th include Sorrento
Sorrento Therapeutics (SRNE) announced that the U.S. Bankruptcy Court for the Southern District of Texas granted interim approval of Sorrento’s $75M debtor-in-possession financing from JMB Capital Partners, in connection with
SAN DIEGO, Feb. 18, 2023 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today posted an IRS Form 8937 (the “Form 8937”) to supplement its previously issued “Frequently Asked Questions” document under the “Investors” section of its website at www.sorrentotherapeutics.com regarding its recent dividend to Sorrento stockholders
SAN DIEGO, Feb. 17, 2023 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today posted an update to its previously issued “Frequently Asked Questions” document under the “Investors” section of its website at www.sorrentotherapeutics.com regarding its recent dividend to Sorrento stockholders of shares of common stock of